Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View:Bullish
| Metric | GILD | IQV |
|---|
| Close | 166.43 | 245.82 |
| Market Cap | $207B | $41.3B |
| 1M | +8.37% | −11.14% |
| P/E (TTM) | — | 29.8 |
| Forward P/E | 20.9 | 19.3 |
| P/E 5-Yr Percentile | — | 53 |
| P/S | 6.7 | 2.4 |
| P/B | 16.0 | 6.2 |
| Dividend Yield | 3.98% | — |
| Latest Quarter Revenue | $8.3B | $4.4B |
| Revenue YoY | +6.8% | +8.0% |
| Gross Margin | 81.1% | — |
| Latest Quarter EPS | 1.94 | 2.10 |
| Avg Post-Earnings Move | ±3.7% | ±2.4% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.65% | 2.81% |
| 90-Day Net Insider Buying | −$41.6M | −$1.9M |
GILD · Revenue, Last 8 Quarters ($B)
IQV · Revenue, Last 8 Quarters ($B)